Search
Displaying results 51 to 60 of 73.
Drug Design and Optimization
In order to combat the increasing number of resistant pathogens, the development of new anti-infective drugs is an important goal for pharmaceutical research. Efficient medications with novel modes-of-action to fight infectious diseases are urgently needed. Below, you may read more about the design, identification and optimisation of new drug candidates. This group is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) .
Drug Bioinformatics
Bioinformatics is instrumental in all areas of molecular biology, from analysis of genome sequences towards predicting three-dimensional structure of drug-target complexes. We apply cutting-edge bioinformatics and computer science techniques for discovery of novel resistance mechanisms and predicting mode-of-action of bioactive compounds. This group is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
Virology and Innate Immunity
Pathogens (germs) infiltrate our bodies daily but do not remain undetected. They encounter the strong defenses of our immune system, which recognizes invaders and promptly takes appropriate measures. However, many pathogens can produce life-long infections even with an intact immune system. The herpesvirus family is one such group of pathogens. Upon infection, herpesviruses establish a chronic infection and become lifelong companions.
Viral Immunology
“Back then, I wasn’t ill so often”: With advancing age not only the skin loses its elasticity – many organs lose their functions. So does the immune system: Defense cells do not react promptly anymore, and immunological memory is not established. As a result, we are poorly protected by vaccines and more susceptible to infections, but at the same time suffer from inflammatory disease. While the mechanisms of immune aging remain unknown, chronic viral infections are environmental factors that may accelerate the age-related changes of the immune system. Read more about how pathogens may have an impact on the real age of our immune system.
Vaccinology and Applied Microbiology
Vaccination is the most efficient strategy to prevent infectious diseases. The art of the vaccine researcher lies in finding substances that prevent us from falling ill with diseases such as influenza or viral hepatitis. But what makes a vaccine successful and ensures effective protection? Our scientists study the reaction of the immune system to answer that question – and to develop better vaccination strategies.
Laboratory of Transmission Immunology
Transmission of viruses is only possible during a specific time frame after infection: we can call this the “window of transmission”. A major gap in mitigating (e.g., airborne) transmission and closing this window quickly is the lack of understanding of critical immune determinants of efficient transmission. To be able to close the window of transmission through the design of better mitigation strategies, we develop a mechanistic understanding of the spatial and longitudinal interplay between virus tropism, innate and adaptive immune responses, changes in host physiology, and exhalation or shedding of infectious virus in droplets or fluids.
Systems Immunology
To see the immune system with the eyes of mathematics – that is the guiding principle of the department Systems Immunology. Mathematical models help to faster and better understand diseases that are associated with immune functions. Read here how scientists use mathematics to investigate chronic inflammatory diseases, the regulation of adaptive immune responses, and the interaction between the nervous, the endocrine and the immune system.
RNA Synthetic Biology
RNA is a ubiquitous molecule of life that plays intimate roles in how cells function and make decisions. These same properties can be harnessed to create a new generation of engineering tools to further interrogate the properties of biology and control how cells behave. The “RNA synthetic biology” group aims to better understand the roles RNA plays in biology and to exploit these roles to improve how we study, diagnose, and treat infectious diseases in humans. This department is located at the Helmholtz Institute for RNA-based Infection Research (HIRI).
Synthetic biology of microbial natural products
The Bozhüyük group focuses on bacterial natural products, with unique structures and bioactive properties. The group studies modular assembly lines like polyketide synthases (PKSs) and non-ribosomal peptide synthetases (NRPSs), which produce many essential clinical agents – but are especially valuable to develop new anti-infectives. This group is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) .
Structural Infection Biology
To understand and eventually manipulate pathways that control the interaction of pathogens (e.g. bacteria, virus, parasite) with their hosts (e.g. human, plants) requires an interdisciplinary research approach, which often combines different fields of research such as cell biology and microbiology. In our laboratory, however, we take a closer look at the processes occurring during an infection at the cellular and atomic level by harnessing a variety of modern biophysical methods that allow addressing the spatio-temporal dynamics of an infectious disease at a high resolution. The department is located at the Center for Structural Systems Biology ( CSSB ) at the heart of the Germany’s largest accelerator center DESY (Deutsches Elektronen-Synchrotron) in Hamburg.